We are live on ! Find out more
SIAU

SB Investment Advisers (UK) Portfolio holdings

AUM $7.73B
1-Year Est. Return 2.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
-2.35%
3 Year Est. Return
+51.59%
5 Year Est. Return
-28.22%
10 Year Est. Return
–
AUM
$9.12B
AUM Growth
+$473M
Cap. Flow
+$347M
Cap. Flow %
3.8%
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$303M
2
OCFT
OneConnect Financial Technology
OCFT
+$44.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 77.23%
2 Healthcare 22.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
1
Uber
UBER
$146B
$6.61B 72.44%
222,228,178
– –
GH icon
2
Guardant Health
GH
$21.3B
$1.79B 19.66%
22,950,460
– –
WORK
3
DELISTED
Slack Technologies, Inc.
WORK
$392M 4.3%
17,458,101
– –
VIR icon
4
Vir Biotechnology
VIR
$1.5B
$284M 3.12%
+22,616,666
New +$303M
OCFT
5
DELISTED
OneConnect Financial Technology
OCFT
$44.6M 0.49%
+444,444
New +$44.1M

Similar funds

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

SB Investment Advisers (UK)'s Q4 2019 Portfolio in Review

As of Q4 2019, SB Investment Advisers (UK) held 5 positions worth $9.12B, up 5.5% from $8.65B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SB Investment Advisers (UK) deployed $347M of net new capital in Q4 2019, opening 2 new positions. Its largest new stake was Vir Biotechnology: 22,616,666 shares worth $284M.

By sector, the portfolio is most concentrated in Technology at 77% of assets, down from 83% a quarter earlier, followed by Healthcare.

  • SB Investment Advisers (UK)'s largest Q4 2019 buy was Vir Biotechnology: 22,616,666 shares worth $284M.
  • SB Investment Advisers (UK)'s ten largest holdings make up 100% of its $9.12B portfolio in Q4 2019.
  • SB Investment Advisers (UK) opened 2 new positions and closed 0 in Q4 2019.
  • SB Investment Advisers (UK)'s portfolio value rose 5.5% quarter-over-quarter to $9.12B.

Based on SB Investment Advisers (UK)'s 13F filing for Q4 2019, filed 14 Feb 2020.